Unlocking the Future of Obesity Treatments with Customized Combos
TLDR: Metsera, a newly emerged biotech funded with $290 million, aims to revolutionize obesity and metabolic disease treatments by creating customizable combinations of injectable and oral peptides. The company was launched during